141 related articles for article (PubMed ID: 36428157)
1. Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: Synthesis, characterization, and biological evaluation.
de Souza CC; de Azevedo-França JA; Barrias E; Cavalcante SCF; Vieira EG; Ferreira AMDC; de Souza W; Navarro M
J Inorg Biochem; 2023 Feb; 239():112047. PubMed ID: 36428157
[TBL] [Abstract][Full Text] [Related]
2. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
[TBL] [Abstract][Full Text] [Related]
3. Candimine from Hippeastrum escoipense (Amaryllidaceae): Anti-Trypanosoma cruzi activity and synergistic effect with benznidazole.
Ortiz JE; Piñeiro M; Martinez-Peinado N; Barrera P; Sosa M; Bastida J; Alonso-Padilla J; Feresin GE
Phytomedicine; 2023 Jun; 114():154788. PubMed ID: 37037085
[TBL] [Abstract][Full Text] [Related]
4. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
[TBL] [Abstract][Full Text] [Related]
5. Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
Strauss M; Lo Presti MS; Bazán PC; Baez A; Fauro R; Esteves B; Sanchez Negrete O; Cremonezzi D; Paglini-Oliva PA; Rivarola HW
Parasitol Int; 2013 Jun; 62(3):293-9. PubMed ID: 23500720
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.
Kratz JM; Garcia Bournissen F; Forsyth CJ; Sosa-Estani S
Expert Rev Clin Pharmacol; 2018 Oct; 11(10):943-957. PubMed ID: 30111183
[TBL] [Abstract][Full Text] [Related]
7. Nanoencapsulation of benznidazole in calcium carbonate increases its selectivity to Trypanosoma cruzi.
Tessarolo LD; de Menezes RRPPB; Mello CP; Lima DB; Magalhães EP; Bezerra EM; Sales FAM; Barroso Neto IL; Oliveira MF; Dos Santos RP; Albuquerque EL; Freire VN; Martins AM
Parasitology; 2018 Aug; 145(9):1191-1198. PubMed ID: 29642963
[TBL] [Abstract][Full Text] [Related]
8. Anti-
Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-
Brito TK; Silva Viana RL; Gonçalves Moreno CJ; da Silva Barbosa J; Lopes de Sousa Júnior F; Campos de Medeiros MJ; Melo-Silveira RF; Almeida-Lima J; de Lima Pontes D; Sousa Silva M; Oliveira Rocha HA
Int J Nanomedicine; 2020; 15():965-979. PubMed ID: 32103950
[TBL] [Abstract][Full Text] [Related]
10. A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole.
Sperandio da Silva GM; Mediano MF; Alvarenga Americano do Brasil PE; da Costa Chambela M; da Silva JA; de Sousa AS; Xavier SS; Rodrigues da Costa A; Magalhães Saraiva R; Hasslocher-Moreno AM
Antimicrob Agents Chemother; 2014 Nov; 58(11):6371-7. PubMed ID: 25114135
[TBL] [Abstract][Full Text] [Related]
11. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
Franco LAM; Moreira CHV; Buss LF; Oliveira LC; Martins RCR; Manuli ER; Lindoso JAL; Busch MP; Pereira AC; Sabino EC
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669428
[TBL] [Abstract][Full Text] [Related]
13. Antiparasitic Effect of Vitamin B12 on Trypanosoma cruzi.
Ciccarelli AB; Frank FM; Puente V; Malchiodi EL; Batlle A; Lombardo ME
Antimicrob Agents Chemother; 2012 Oct; 56(10):5315-20. PubMed ID: 22869565
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory, trypanocide, and antioxidant properties of essential oil fractions of Lippia alba (Verbenaceae).
Quintero WL; Moreno EM; Pinto SML; Sanabria SM; Stashenko E; García LT
BMC Complement Med Ther; 2021 Jul; 21(1):187. PubMed ID: 34215249
[TBL] [Abstract][Full Text] [Related]
15. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
16. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
17. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
18. Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol.
Cafferata ML; Toscani MA; Althabe F; Belizán JM; Bergel E; Berrueta M; Capparelli EV; Ciganda Á; Danesi E; Dumonteil E; Gibbons L; Gulayin PE; Herrera C; Momper JD; Rossi S; Shaffer JG; Schijman AG; Sosa-Estani S; Stella CB; Klein K; Buekens P
Reprod Health; 2020 Aug; 17(1):128. PubMed ID: 32831069
[TBL] [Abstract][Full Text] [Related]
19. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
20. 1,3-Thiazole derivatives as privileged structures for anti-Trypanosoma cruzi activity: Rational design, synthesis, in silico and in vitro studies.
Cox Holanda de Barros Dias M; Souza Barbalho M; Bezerra de Oliveira Filho G; Veríssimo de Oliveira Cardoso M; Lima Leite AC; da Silva Santos AC; Cristovão Silva AC; Accioly Brelaz de Castro MC; Maria Nascimento Moura D; Gomes Rebello Ferreira LF; Zaldini Hernandes M; de Freitas E Silva R; Rêgo Alves Pereira V
Eur J Med Chem; 2023 Sep; 257():115508. PubMed ID: 37267753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
